Vendor, Frederick, MD
Medigen, Inc.
UEI MGLJHKGKWBL3, CAGE 4XUZ4
1 award and $2,307,491 obligated between July 2, 2026 and August 24, 2026, 100% under full and open competition, against 27.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $2,307,491 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00034Definitive Contract, July 2, 2026, Full and Open Competition, 27 offers | National Institutes of Health NiaidNational Institutes of Health | Eo 14398 to Develop a Lassa Fever VaccineNAICS 541714, PSC AN11 | $2,307,491 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards